Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostat... by Vargas, Carlos E., MD, Schmidt, Matthew Q., MD, Niska, Joshua R., MD, Hartsell, William F., MD, Keole, Sameer R., MD, Doh, Lucius, MD, Chang, John Han-Chih, MD, Sinesi, Christopher, MD, Rodriquez, Rossio, CTR, Pankuch, Mark, PhD, Larson, Gary L., MD

Get full text